HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

NCT/Study#

N/A /

CD34-REAGENT-SYSTEM-GVHD

This protocol is for the use of CliniMACS CD34 Reagent System in a single patient with relapsed AML. Patient received salvage chemo and planned stem cell boost for cytopenias. Since donor is a haplo, plan is to give CD34 selected cells with some t cell add back.

DISEASE GROUP:
Bone Marrow Transplant
current phase:
N/A
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information: